<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Dolby Laboratories, Inc. (DLB) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/dlb/</link>
<description>Every dated entry in the public record on Dolby Laboratories, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/dlb/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Fri, 09 Oct 2026 00:00:00 +0000</lastBuildDate>
<item><title>Dolby Laboratories, Inc.: Couling John D (SVP, Entertainment) sold 6,831 shares at $58.72 on 1 October 2026, $401,092</title><link>https://greeksoup.ai/stocks/us/dlb/insiders/</link><guid isPermaLink="false">us:DLB:insider:2026-10-05:db21c8216e</guid><pubDate>Mon, 05 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526414725/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Couling John D (SVP, Entertainment) sold 836 shares at $59.33 on 1 October 2026, $49,598</title><link>https://greeksoup.ai/stocks/us/dlb/insiders/</link><guid isPermaLink="false">us:DLB:insider:2026-10-05:8933512be8</guid><pubDate>Mon, 05 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526414725/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Form 144, JOHN COULING plans to sell 7,667 shares worth $450,689 around 1 October 2026</title><link>https://greeksoup.ai/stocks/us/dlb/planned-sales/</link><guid isPermaLink="false">us:DLB:planned-sale:2026-10-01:4cf1f4ea6d</guid><pubDate>Thu, 01 Oct 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000195004726009927/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: short interest 5,530,847 shares at the 15 September 2026 settlement, 6.01 days to cover</title><link>https://greeksoup.ai/stocks/us/dlb/short-interest/</link><guid isPermaLink="false">us:DLB:short-interest:2026-09-15:a6e8f0d0f9</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc. filed S-8: s-8</title><link>https://greeksoup.ai/stocks/us/dlb/filings/</link><guid isPermaLink="false">us:DLB:filing:2026-09-11:93ab78ebd1</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526389337/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Couling John D (SVP, Entertainment) sold 7,667 shares at $61.05 on 1 September 2026, $468,032</title><link>https://greeksoup.ai/stocks/us/dlb/insiders/</link><guid isPermaLink="false">us:DLB:insider:2026-09-03:21e897e579</guid><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526382329/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Form 144, JOHN COULING plans to sell 7,667 shares worth $468,032 around 1 September 2026</title><link>https://greeksoup.ai/stocks/us/dlb/planned-sales/</link><guid isPermaLink="false">us:DLB:planned-sale:2026-09-01:efc59df1ef</guid><pubDate>Tue, 01 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000195004726008913/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: short interest 5,532,041 shares at the 31 August 2026 settlement, 5.53 days to cover</title><link>https://greeksoup.ai/stocks/us/dlb/short-interest/</link><guid isPermaLink="false">us:DLB:short-interest:2026-08-31:37ada62e53</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc. filed 8-K: officer or director change, regulation fd disclosure, other events</title><link>https://greeksoup.ai/stocks/us/dlb/filings/</link><guid isPermaLink="false">us:DLB:filing:2026-08-27:4d9be8424b</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526369707/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Nicholson Ryan (VP, CAO and Corp. Controller) sold 1,183 shares at $65.28 on 25 August 2026, $77,223</title><link>https://greeksoup.ai/stocks/us/dlb/insiders/</link><guid isPermaLink="false">us:DLB:insider:2026-08-27:423404f259</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526371803/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Form 144, RYAN H NICHOLSON plans to sell 1,183 shares worth $77,223 around 25 August 2026</title><link>https://greeksoup.ai/stocks/us/dlb/planned-sales/</link><guid isPermaLink="false">us:DLB:planned-sale:2026-08-25:38327ac959</guid><pubDate>Tue, 25 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000195004726008651/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Revankar Shriram (SVP, Advanced Technology Group) sold 3,000 shares at $62.71 on 14 August 2026, $188,130</title><link>https://greeksoup.ai/stocks/us/dlb/insiders/</link><guid isPermaLink="false">us:DLB:insider:2026-08-18:ca6492a6f3</guid><pubDate>Tue, 18 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526355688/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Form 144, SHRIRAM REVANKAR plans to sell 3,000 shares worth $188,130 around 14 August 2026</title><link>https://greeksoup.ai/stocks/us/dlb/planned-sales/</link><guid isPermaLink="false">us:DLB:planned-sale:2026-08-14:a36d1871c2</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000195004726008129/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: short interest 5,888,989 shares at the 14 August 2026 settlement, 6.52 days to cover</title><link>https://greeksoup.ai/stocks/us/dlb/short-interest/</link><guid isPermaLink="false">us:DLB:short-interest:2026-08-14:b98a574444</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Nicholson Ryan (VP, CAO and Corp. Controller) sold 1,348 shares at $62.04 on 10 August 2026, $83,630</title><link>https://greeksoup.ai/stocks/us/dlb/insiders/</link><guid isPermaLink="false">us:DLB:insider:2026-08-12:5d8e6bf74d</guid><pubDate>Wed, 12 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526346962/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Form 144, RYAN H NICHOLSON plans to sell 1,348 shares worth $83,630 around 10 August 2026</title><link>https://greeksoup.ai/stocks/us/dlb/planned-sales/</link><guid isPermaLink="false">us:DLB:planned-sale:2026-08-10:a9e8b5dc7a</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000195004726007856/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Nicholson Ryan (VP, CAO and Corp. Controller) sold 357 shares at $60.63 on 4 August 2026, $21,645</title><link>https://greeksoup.ai/stocks/us/dlb/insiders/</link><guid isPermaLink="false">us:DLB:insider:2026-08-06:7711ae933f</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526338476/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Couling John D (SVP, Entertainment) sold 783 shares at $59.03 on 3 August 2026, $46,224</title><link>https://greeksoup.ai/stocks/us/dlb/insiders/</link><guid isPermaLink="false">us:DLB:insider:2026-08-05:7ed0af201d</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526335473/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Couling John D (SVP, Entertainment) sold 6,884 shares at $60.11 on 3 August 2026, $413,780</title><link>https://greeksoup.ai/stocks/us/dlb/insiders/</link><guid isPermaLink="false">us:DLB:insider:2026-08-05:1c89be0123</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526335473/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: Form 144, JOHN COULING plans to sell 7,667 shares worth $460,004 around 3 August 2026</title><link>https://greeksoup.ai/stocks/us/dlb/planned-sales/</link><guid isPermaLink="false">us:DLB:planned-sale:2026-08-03:ade23601c3</guid><pubDate>Mon, 03 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000195004726007493/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: short interest 6,301,569 shares at the 31 July 2026 settlement, 6.47 days to cover</title><link>https://greeksoup.ai/stocks/us/dlb/short-interest/</link><guid isPermaLink="false">us:DLB:short-interest:2026-07-31:27fdc24033</guid><pubDate>Fri, 31 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc. Q3 FY2026 results: revenue $305 million, net income $29 million</title><link>https://greeksoup.ai/stocks/us/dlb/results/fy2026-q3/</link><guid isPermaLink="false">us:DLB:result:2026-07-30:f404fa2d4b</guid><pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001308547&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/results/fy2026-q3/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc. filed 10-Q: 10-q</title><link>https://greeksoup.ai/stocks/us/dlb/filings/</link><guid isPermaLink="false">us:DLB:filing:2026-07-30:5228024f34</guid><pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000130854726000013/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc. filed 8-K: results of operations, other events</title><link>https://greeksoup.ai/stocks/us/dlb/filings/</link><guid isPermaLink="false">us:DLB:filing:2026-07-30:91e84aa886</guid><pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1308547/000119312526326149/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Dolby Laboratories, Inc.: short interest 6,755,162 shares at the 15 July 2026 settlement, 6.95 days to cover</title><link>https://greeksoup.ai/stocks/us/dlb/short-interest/</link><guid isPermaLink="false">us:DLB:short-interest:2026-07-15:192e7fd94a</guid><pubDate>Wed, 15 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dlb/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
